NCT00794144View on ClinicalTrials.gov

Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age

PHASE2CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2008

Conditions
Allergic Rhinitis
Interventions
DRUG

Olopatadine Hydrochloride Nasal Spray 0.6%

one spray in each nostril twice daily for 2 weeks

DRUG

Olopatadine Hydrochloride Nasal Spray Vehicle

one spray in each nostril twice daily for 2 weeks

Trial Locations (1)

76712

Niran Amar, M.D., Waco

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00794144 - Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age | Biotech Hunter | Biotech Hunter